SEPPA-mAb: spatial epitope prediction of protein antigens for mAbs
Nucleic Acids Research · 05.07.2023 · 51 (W1) · W528-W534
DOI: 10.1093/nar/gkad427 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 22.05.2023. Verfasst von Tianyi Qiu und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Fudan University, Shanghai 200092, China. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Epitopes, Software. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Shanghai Sailing Program.
Abstract (Originalsprache)
Identifying the exact epitope positions for a monoclonal antibody (mAb) is of critical importance yet highly challenging to the Ab design of biomedical research. Based on previous versions of SEPPA 3.0, we present SEPPA-mAb for the above purpose with high accuracy and low false positive rate (FPR), suitable for both experimental and modelled structures. In practice, SEPPA-mAb appended a fingerprints-based patch model to SEPPA 3.0, considering the structural and physic-chemical complementarity between a possible epitope patch and the complementarity-determining region of mAb and trained on 860 representative antigen-antibody complexes. On independent testing of 193 antigen-antibody pairs, SEPPA-mAb achieved an accuracy of 0.873 with an FPR of 0.097 in classifying epitope and non-epitope residues under the default threshold, while docking-based methods gave the best AUC of 0.691, and the top epitope prediction tool gave AUC of 0.730 with balanced accuracy of 0.635. A study on 36 independent HIV glycoproteins displayed a high accuracy of 0.918 and a low FPR of 0.058. Further testing illustrated outstanding robustness on new antigens and modelled antibodies. Being the first online tool predicting mAb-specific epitopes, SEPPA-mAb may help to discover new epitopes and design better mAbs for therapeutic and diagnostic purposes. SEPPA-mAb can be accessed at http://www.badd-cao.net/seppa-mab/.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Fudan University, Shanghai 200092, China.
- Institute of Clinical Science, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
- Shanghai Tenth People's Hospital, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.
ORCID-Profile: Tianyi Qiu, Zikun Chen, Genhui Zheng, Deyu Yan, Kailin Tang
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Shanghai Sailing Program
Zitieren
APA
Qiu, T., Zhang, L., Chen, Z., Wang, Y., Mao, T., Wang, C., Cun, Y., Zheng, G., Yan, D., Zhou, M., Tang, K., & Cao, Z. (2023). SEPPA-mAb: spatial epitope prediction of protein antigens for mAbs. Nucleic Acids Research, 51(W1), W528-W534. https://doi.org/10.1093/nar/gkad427
Vancouver
Qiu T, Zhang L, Chen Z, Wang Y, Mao T, Wang C, et al. SEPPA-mAb: spatial epitope prediction of protein antigens for mAbs. Nucleic Acids Research. 2023;51(W1):W528-W534. doi:10.1093/nar/gkad427
BibTeX
@article{Qiu2023,
author = {Qiu, Tianyi and Zhang, Lu and Chen, Zikun and Wang, Yuan and Mao, Tiantian and Wang, Caicui and Cun, Yewei and Zheng, Genhui and Yan, Deyu and Zhou, Mengdi and Tang, Kailin and Cao, Zhiwei},
title = {SEPPA-mAb: spatial epitope prediction of protein antigens for mAbs},
journal = {Nucleic Acids Research},
year = {2023},
volume = {51},
number = {W1},
pages = {W528--W534},
doi = {10.1093/nar/gkad427}
}
EUVIMED